Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer

NDAQ:APHA - Post by User

Aphria Inc.

Bullboard Posts

Comment by Bella2017on Mar 07, 2018 12:30pm

91 Views

Post# 27676303

RE:Aphria Investor Deck ...looks updated to me

Thank you rwilliam,

Aphria becomes global medical cannabis leader with presence in 11 countries – and counting:

Aphria

CANADA Cultivation & sale licenses 230,000kg capacity

UNITED STATES Investments in Liberty Health Sciences

AUSTRALIA • 25% ownership in Althea Company Pty Ltd. including supply agreement
• Supply agreements with Medlab Clinical

Nuuvera

GERMANY • Shortlisted by BFARM for a contract to grow, process, store and deliver up to 6,000kg of cannabis
• Supply relationship with significant pharmaceutical distribution company servicing over 13,000 pharmacies (1,200kgs initial order)

URUGUAY Supply agreement (30kgs/month of CBD isolate) LESOTHO Supply agreement (100kgs/month of extract)

ISRAEL Established presence and relationships

UNITED KINGDOM Import agreement for pharma-grade CBD isolate (into 30kg/month) CANADA MOU for New Brunswick (2,500kg)

ITALY Owner of Italian subsidiary with 1 of 7 import/distribution license

SPAIN • LOI for JV with local partner, Cafina, included supply agreement
• LOI to acquire GMP facility

MALTA • LOI for JV with local partners
• LOI for acquisition of GMP facility

CANADA MOU for New Brunswick (2,500kg)